<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d563" origId="Decitabine"><sentence id="DrugDDI.d563.s0" origId="s0" text="Drug interaction studies with decitabine have not been conducted."><entity charOffset="30-40" id="DrugDDI.d563.s0.e0" origId="s0.p2" text="decitabine" type="drug"/><negationtags>&lt;xcope&gt;Drug interaction studies with decitabine have &lt;cue&gt;not&lt;/cue&gt; been conducted&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d563.s1" origId="s1" text="In vitro studies in human liver microsomes suggest that decitabine is unlikely to inhibit or induce cytochrome P450 enzymes."><entity charOffset="56-66" id="DrugDDI.d563.s1.e0" origId="s1.p10" text="decitabine" type="drug"/><entity charOffset="100-115" id="DrugDDI.d563.s1.e1" origId="s1.p16" text="cytochrome P450" type="drug"/><pair e1="DrugDDI.d563.s1.e0" e2="DrugDDI.d563.s1.e1" id="DrugDDI.d563.s1.p0" interaction="false"/></sentence><sentence id="DrugDDI.d563.s2" origId="s2" text="In vitro metabolism studies have suggested that decitabine is not a substrate for the human liver cytochrome P450 enzymes."><entity charOffset="48-58" id="DrugDDI.d563.s2.e0" origId="s2.p20" text="decitabine" type="drug"/><entity charOffset="98-120" id="DrugDDI.d563.s2.e1" origId="s2.p23" text="cytochrome p450 enzyme" type="drug"/><pair e1="DrugDDI.d563.s2.e0" e2="DrugDDI.d563.s2.e1" id="DrugDDI.d563.s2.p0" interaction="false"/><negationtags>In vitro metabolism studies have suggested that decitabine is &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; a substrate for the human liver cytochrome P450 enzymes&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d563.s3" origId="s3" text="As plasma protein binding of decitabine is negligible ( 1%), interactions due to displacement of more highly protein bound drugs from plasma proteins are not expected."><entity charOffset="3-17" id="DrugDDI.d563.s3.e0" origId="s3.p24" text="plasma protein" type="drug"/><entity charOffset="29-39" id="DrugDDI.d563.s3.e1" origId="s3.p25" text="decitabine" type="drug"/><entity charOffset="134-149" id="DrugDDI.d563.s3.e2" origId="s3.p35" text="plasma proteins" type="drug"/><pair e1="DrugDDI.d563.s3.e0" e2="DrugDDI.d563.s3.e1" id="DrugDDI.d563.s3.p0" interaction="false"/><pair e1="DrugDDI.d563.s3.e0" e2="DrugDDI.d563.s3.e2" id="DrugDDI.d563.s3.p1" interaction="false"/><pair e1="DrugDDI.d563.s3.e1" e2="DrugDDI.d563.s3.e2" id="DrugDDI.d563.s3.p2" interaction="false"/><negationtags>As plasma protein binding of decitabine is negligible ( 1%), interactions due to displacement of more highly protein bound drugs from plasma proteins are &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; expected&lt;/xcope&gt;.</negationtags></sentence></document>